Therapeutic angiogenesis: time for the next phase.
Pantely
G A
GA
Porter
J M
JM
D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects; D004333:Drug Administration Routes; D016228:Endothelial Growth Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D016222:Fibroblast Growth Factor 2 / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007511:Ischemia / Q000188:drug therapy* / Q000503:physiopathology; D008222:Lymphokines / Q000008:administration & dosage / Q000627:therapeutic use*; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D020033:Protein Isoforms / Q000008:administration & dosage / Q000627:therapeutic use*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D020033:Protein Isoforms; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016222:Fibroblast Growth Factor 2